T Cell Studies Point to Immune Tuning, Not Simple Boosting
New T cell studies on cysteine metabolism and dormant Tregs show why cancer and asthma therapies may depend on tuning immune cells, not just boosting or suppressing them.
Showing 73-84 of 206 articles
New T cell studies on cysteine metabolism and dormant Tregs show why cancer and asthma therapies may depend on tuning immune cells, not just boosting or suppressing them.
University of Oulu studies used ultrafast MRI to track sleep-related brain pulsations in healthy volunteers without contrast agents or clinical claims.
HHS restored the ONC name and moved AI, data and technology roles to OCIO, narrowing the health tech office while raising execution questions.
Consultants in England backed industrial action on 51.53% turnout, while a separate SAS doctor ballot missed the legal participation threshold.
Lilly's Centessa takeover and Biogen's Apellis acquisition show big pharma favoring targeted biotech assets over disruptive mega-mergers.
Families say IVF treatment in northern Cyprus left seven children with genetic profiles that did not match the donors their parents selected.
Keir Starmer's March ultimatum tied resident doctors' strike action to training posts, but a later accepted deal restored a larger three-year expansion.
A national survey of upper-year U.S. family medicine residents links three or more hours of nightly EHR work with burnout and lower satisfaction.
In TARTAN-HF, an NT-proBNP test followed by echocardiography identified substantially more heart failure than usual care among high-risk adults with diabetes.
A UNSW-led review says nicotine vapes are likely to cause lung and oral cancers, but the strongest warning is biological, not decades-long population proof.
AI tools using retinal images and heart-fat measurements could flag cardiovascular risk earlier, but the test is whether health systems act on alerts.
A Mass General Brigham study tested an autonomous AI workflow on 3,338 clinical notes, finding high specificity but only 62% sensitivity in validation.